Application 204946
- Type
- ANDA
- Sponsor
- ZYDUS PHARMS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | FESOTERODINE FUMARATE | FESOTERODINE FUMARATE | TABLET, EXTENDED RELEASE;ORAL | 4MG | No | No |
| 002 | FESOTERODINE FUMARATE | FESOTERODINE FUMARATE | TABLET, EXTENDED RELEASE;ORAL | 8MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A204946-001 | FESOTERODINE FUMARATE | FESOTERODINE FUMARATE | 4MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2017-10-03 | |
| A204946-002 | FESOTERODINE FUMARATE | FESOTERODINE FUMARATE | 8MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2017-10-03 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A204946-001 | AB |
| A204946-002 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A204946-001 | FESOTERODINE FUMARATE | 4MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2017-10-03 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A204946-002 | FESOTERODINE FUMARATE | 8MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2017-10-03 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A204946-001 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A204946-002 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| fesoterodine fumarate | FESOTERODINE FUMARATE | Zydus Pharmaceuticals USA Inc. | 8c68e918-b47b-466d-80bc-4f521aa74607 | 2025-01-01 | Warnings, Adverse reactions | 204946 ANDA204946 68382-480 68382-479 |
| fesoterodine fumarate | FESOTERODINE FUMARATE | Zydus Lifesciences Limited | 26e8cc63-1e1d-4a77-8f53-4c38bcf0d443 | 2024-11-30 | 204946 ANDA204946 70771-1169 70771-1168 |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 68382-479 | fesoterodine fumarate | fesoterodine fumarate | Zydus Pharmaceuticals USA Inc. | ANDA | Current |
| 68382-479 | fesoterodine fumarate | fesoterodine fumarate | Zydus Pharmaceuticals (USA) Inc. | ANDA | Current |
| 68382-479 | fesoterodine fumarate | fesoterodine fumarate | Zydus Pharmaceuticals (USA) Inc. | ANDA | Current |
| 68382-479 | fesoterodine fumarate | fesoterodine fumarate | Zydus Pharmaceuticals (USA) Inc. | ANDA | Current |
| 68382-479 | fesoterodine fumarate | fesoterodine fumarate | Zydus Pharmaceuticals (USA) Inc. | ANDA | Current |
| 68382-480 | fesoterodine fumarate | fesoterodine fumarate | Zydus Pharmaceuticals USA Inc. | ANDA | Current |
| 68382-480 | fesoterodine fumarate | fesoterodine fumarate | Zydus Pharmaceuticals (USA) Inc. | ANDA | Current |
| 68382-480 | fesoterodine fumarate | fesoterodine fumarate | Zydus Pharmaceuticals (USA) Inc. | ANDA | Current |
| 68382-480 | fesoterodine fumarate | fesoterodine fumarate | Zydus Pharmaceuticals (USA) Inc. | ANDA | Current |
| 68382-480 | fesoterodine fumarate | fesoterodine fumarate | Zydus Pharmaceuticals (USA) Inc. | ANDA | Current |
| 70771-1168 | fesoterodine fumarate | fesoterodine fumarate | Cadila Healthcare Limited | ANDA | Current |
| 70771-1168 | fesoterodine fumarate | fesoterodine fumarate | Cadila Healthcare Limited | ANDA | Current |
| 70771-1168 | fesoterodine fumarate | fesoterodine fumarate | Cadila Healthcare Limited | ANDA | Current |
| 70771-1168 | fesoterodine fumarate | fesoterodine fumarate | Zydus Lifesciences Limited | ANDA | Current |
| 70771-1169 | fesoterodine fumarate | fesoterodine fumarate | Cadila Healthcare Limited | ANDA | Current |
| 70771-1169 | fesoterodine fumarate | fesoterodine fumarate | Cadila Healthcare Limited | ANDA | Current |
| 70771-1169 | fesoterodine fumarate | fesoterodine fumarate | Cadila Healthcare Limited | ANDA | Current |
| 70771-1169 | fesoterodine fumarate | fesoterodine fumarate | Zydus Lifesciences Limited | ANDA | Current |